Classification of Actifresh and Plethico Mint as sugar confectionery upheld; Plethico Byte and Travisil deemed ayurvedic medicines.

The Tribunal classified products Actifresh and Plethico Mint as sugar confectionery under heading 1704 due to lack of therapeutic value, while Plethico Byte and Travisil were deemed ayurvedic medicines under heading 3004 for their therapeutic properties. The Tribunal emphasized that a product's use and intended therapeutic benefits, not just active ingredients, determine its classification. The Revenue's appeal was partially allowed, adjusting duty liability accordingly. The decision was based on thorough analysis of ingredients, therapeutic properties, and legal precedents, ensuring a reasoned outcome under the Central Excise Tariff.

---

---

Issues: Classification of products as ayurvedic medicines or sugar confectionery under the Central Excise Tariff.

Analysis:
1. The dispute in this case revolves around the classification of products named Actifresh, Plethico Mint, Plethico Byte, and Travisil under the Central Excise Tariff. The Revenue contended that these products should be classified as sugar confectionery under heading 1704, while the respondent argued for their classification as ayurvedic medicines under sub-heading 300400 of the tariff.

2. The Department issued Show Cause Notices based on the judgment in the case of Warner Hindustan Ltd. vs Collector, where it was held that products with small quantities of certain ingredients may not qualify as ayurvedic medicines. The Revenue appealed against the original order classifying the products as ayurvedic medicines, leading to the present appeal.

3. The composition of the products was analyzed, with Actifresh and Plethico Mint primarily containing sugar and glucose with small quantities of flavoring agents like pudina ark and nilgiri oil. Plethico Byte contained mulethi, known for its therapeutic properties, while Travisil included various herbs with therapeutic value for sore throat relief.

4. The Tribunal referred to the HSN explanatory notes for heading 1704, which include preparations with medicinal properties under chapter 30, provided they have therapeutic or prophylactic uses. Actifresh and Plethico Mint were classified as sugar confectionery due to the lack of therapeutic value in their ingredients, while Plethico Byte and Travisil were considered ayurvedic medicines for their therapeutic properties.

5. The Tribunal cited the apex court's ruling in CCE Calcutta vs Sharma Medical Works to emphasize that the percentage of active ingredients does not solely determine a product's classification as a medicament. The main criteria are the product's use and intended therapeutic benefits, not necessarily requiring a doctor's prescription for classification.

6. Consequently, the Tribunal upheld the classification of Plethico Byte and Travisil as ayurvedic medicines under heading 3004, while reclassifying Actifresh and Plethico Mint as sugar confectionery under heading 1704. The Revenue's appeal was partly allowed, with the duty liability adjusted accordingly.

7. In conclusion, the Tribunal's detailed analysis considered the ingredients, therapeutic properties, and classification criteria to determine the appropriate categorization of the products under the Central Excise Tariff, ensuring a fair and reasoned decision based on legal precedents and statutory provisions.

---